GGrantIndex
Sort

46,585 grants matching heart failure

Developing a MRI-guided Disease-Modifying Therapy for Post Infarction Chronic Heart Failure

$867,419
David M. Underhill · Cedars-Sinai Medical Center · R01 · FY2020 · HL

Drosophila models of human mitochondrial diseases

$867,258
Norbert Perrimon · Harvard Medical School · R24 · FY2023 · OD

Developing a MRI-guided Disease-Modifying Therapy for Post Infarction Chronic Heart Failure

$867,246
Rohan Dharmakumar · Cedars-Sinai Medical Center · R01 · FY2019 · HL

Non-Modulation Phenotype and Vascular Dysfunction in Diabetes Mellitus

$867,235
Gordon H Williams · Brigham And Women'S Hospital · R01 · FY2008 · HL

A FUNCTIONAL GENOMICS HEART &LUNG DEVELOP. PROGRAM

$867,210
Children'S Research Institute · U01 · FY2002 · HL

The Vanderbilt Emergency Medicine Research Training Program (VEMRT)

$867,113
Alan B Storrow · Vanderbilt University · K12 · FY2013 · HL

Bioelectric monitoring and neuromodulation of the heart

$867,081
Jeffrey L Ardell · University Of California Los Angeles · R01 · FY2023 · HL

Developing a MRI-guided Disease-Modifying Therapy for Post Infarction Chronic Heart Failure

$867,048
Rohan Dharmakumar · Cedars-Sinai Medical Center · R01 · FY2018 · HL

Chronic Kidney Disease in Children (CKiD)

$866,980
Susan L Furth · Children'S Hosp Of Philadelphia · U01 · FY2010 · DK

Deciphering how 3D genome organization orchestrates cardiac cellular identity

$866,689
Rajan Jain · University Of Pennsylvania · R35 · FY2024 · HL

Digital Technology to Support Adherence to Hypertension Medications for Older Adults with Mild Cognitive Impairment

$866,473
Kathleen C Insel · University Of Arizona · R01 · FY2023 · NR

Studies in pig-to-primate cardiac xenotransplantation

$866,429
Christopher G.a. Mc Gregor · Mayo Clinic Rochester · U01 · FY2009 · AI

Renewing the heart: cardiomyocyte cell cycle regulation

$866,250
Sylvia M Evans · University Of California, San Diego · R35 · FY2020 · HL

Mindful Steps: A Web-Based Mind-Body Exercise Intervention to Promote Physical Activity in Chronic Cardiopulmonary Disease

$866,048
Gloria Y Yeh · Beth Israel Deaconess Medical Center · R01 · FY2023 · AT

A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events

$865,807
Robert Yeh · Beth Israel Deaconess Medical Center · R01 · FY2023 · HL

Phase II Trial Evaluating the Safety and Efficacy of an Allogeneic Stem Cell for

$865,500
Anthony Ting · Athersys, Inc. · R44 · FY2015 · HL

Ultrasound-Targeted Therapy for Acute Myocardial Infarction

$865,473
Sanjiv Kaul · Oregon Health & Science University · R01 · FY2010 · HL

Diabetes and Heart Disease Risk in Blacks

$865,452
Anne Sumner · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK

Claude D. Pepper Older Americans Independence Center (OAIC)

$865,368
Marco Pahor · University Of Florida · P30 · FY2007 · AG

Cardiorenal Genomics for Risk Prediction in African Descent Populations

$865,361
Marguerite R Irvin · University Of Alabama At Birmingham · R35 · FY2023 · HL

Renewing the heart: cardiomyocyte cell cycle regulation

$865,334
Sylvia M Evans · University Of California, San Diego · R35 · FY2019 · HL

Novel Biomarkers to Predict Readmission in Pediatric and Adult Heart Surgery

$864,961
Jeremiah R Brown · Dartmouth College · R01 · FY2014 · HL

The kinase toolbox: Mapping the spatial and temporal regulation of cell signaling

$864,792
Sivaraj Sivaramakrishnan · University Of Michigan At Ann Arbor · DP2 · FY2013 · CA

Gadolinium Free Cardiac MR Imaging of Scar and Fibrosis

$864,762
Reza Nezafat · Beth Israel Deaconess Medical Center · R01 · FY2021 · HL

A mobile health framework for left ventricular end diastolic pressure diagnostics and monitoring.

$864,759
Kaustubh Kale · Aventusoft, Llc · R44 · FY2024 · HL